Editorial
Welcome to eurotimes.org an online service for ophthalmologists supported by the European Cataract and Refractive Surgeons Society (ESCRS).
Founded in 1991, the ESCRS is Europe's leading organisation for cataract and refractive surgeons and is at the forefront of developments in anterior segment surgery. The society currently has more than 4,000 members from over 90 different countries worldwide. The ESCRS offers a unique forum for discussion and learning which ensures that international expertise is shared by ophthalmologists all over Europe.
This website includes content from EuroTimes, the official news magazine of the ESCRS, and also links to our other online activities including Podcasts, Facebook and Twitter. As Chairman of the ESCRS Publications Committee, and also on behalf of my fellow Editors Jose Guell, Ioannis Pallikaris, Clive Peckar and Paul Rosen, I welcome the views and comments from ophthalmologists visiting the website as to how we can maintain and improve our online services.
Thank you for your support
Emanuel Rosen, ESCRS Publications Committee Chairman
Latest Articles
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.